Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

DOI Full Paper Access

118

Citations

22

References

2014

Year

Harpreet Wasan, Angela Meade, Richard Adams, Richard H. Wilson, Cheryl Pugh, David J. Fisher, Benjamin Sydes, Ayman Madi, Bruce Sizer, C. Lowdell,

The Lancet Oncology

References

	Year	Citations

Page 1